PILOT 2006 Disclosure

PILOT™ Steering Committee

Program Chairperson

Paul W. Noble, MD, FCCP

Committee Members

Jeffrey A. Golden, MD	Glenn D. Rosen, MD
Kevin O. Leslie, MD	Steven A. Sahn, MD
Steven D. Nathan, MD	W. Richard Webb, MD
Maria L. Padilla, MD

Paul W. Noble, MD, FCCP, has served as a consultant for Actelion, Boehringer Ingelheim, CoTherix, Genzyme, InterMune, Johnson & Johnson, Novartis, and Wyeth. He served on a scientific advisory board for Icos and as an investigator for Boehringer Ingelheim, CoTherix, and Intermune.

Jeffrey A. Golden, MD, has nothing to disclose.

Kevin O. Leslie, MD, has nothing to disclose.

Steven D. Nathan, MD, has served as a consultant and speaker for and received research funding from Actelion and InterMune, and has received research funding from and is a speaker for CoTherix.

Maria L. Padilla, MD, has served as a consultant, investigator, and speaker for InterMune. She has also served as an investigator for CoTherix.

Glenn D. Rosen, MD, has served as a speaker and has served on advisory boards for InterMune.

Steven A. Sahn, MD, has served on advisory boards for InterMune and Kindred Hospitals, and is a speaker for Boeringher Ingelheim, GlaxoSmithKline, and InterMune.

W. Richard Webb, MD, has served on an advisory board for InterMune.

Other Contributing Faculty

Kevin K. Brown, MD	Ganesh Raghu, MD, FACP, FCCP
Harold R. Collard, MD, FCCP	Marvin I. Schwarz, MD
James H. Dauber, MD	Charles Strange, MD
Kevin R. Flaherty, MD, MS	Robert M. Strieter, MD
Robert J. Homer, MD, PhD	Victor J. Thannickal, MD
Yolanda N. Mageto, MD	Timothy Whelan, MD
Imre Noth, MD	David A. Zisman, MD

Kevin K. Brown, MD, has served as a consultant for Actelion, Arizeke, Encysive, FibroGen, Genzyme, InterMune, and Wyeth.

Harold R. Collard, MD, FCCP, has served as a consultant for InterMune.

James H. Dauber, MD, has served on speaker's bureaus and on advisory boards for InterMune.

Kevin R. Flaherty, MD, MS, has nothing to disclose.

Robert J. Homer, MD, PhD, has nothing to disclose.

Yolanda N. Mageto, MD, has served on the speaker's bureau for InterMune.

Imre Noth, MD, has served as clinical investigator for Actelion, CoTherix, InterMune, and Wyeth.

Ganesh Raghu, MD, FACP, FCCP, serves as an advisor, consultant, and clinical trial investigator for Actelion, FibroGen, Genzyme, InterMune, and Shionogi.

Marvin I. Schwarz, MD, has nothing to disclose.

Charles Strange, MD, has nothing to disclose.

Robert M. Strieter, MD, has served as a speaker for Biogen Idec, InterMune, and Novartis.

Victor J. Thannickal, MD, has nothing to disclose.

Timothy Whelan, MD, has received research funding from Actelion and InterMune, and has served on the speaker's bureau for InterMune.

David A. Zisman, MD, has nothing to disclose.

Disclaimer
The opinions, recommendations, and guidelines expressed herein are those of the PILOT™ Steering Committee and other contributing faculty, and not necessarily those of The France Foundation or InterMune, who assume no responsibility or liability for the material that appears herein.